Inhaled glycopyrronium on excessive sialorrhea and drooling
- Conditions
- Sialorrhea, drooling, Parkinson Disease.Speekselvloed, kwijlen, Ziekte van Parkinson
- Registration Number
- NL-OMON27582
- Lead Sponsor
- Medisch Spectrum Twente, Enschede
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Diagnosed with Parkinson disease
Moderate to severe sialorrhea, defined as a minimum of 4 of the Mier scale
Exclusion Criteria
Hypersensitivity to glycopyrronium or other excipients
Use of medication with known anticholinergic effects.
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The safety and tolerability of glycopyrronium inhalation powder in patients diagnosed with sialorrhea and parkinson disease, measured in adverse events and other special events that occur.
- Secondary Outcome Measures
Name Time Method Het mean difference in drooling between different dosing regimes and the patient preference.